MK-677, also called ibutamoren, is an experimental drug that stimulates your body’s own production of growth hormone. It works by mimicking ghrelin, the “hunger hormone,” binding to the same receptors in the brain that ghrelin normally activates. This triggers the pituitary gland to release more growth hormone and, in turn, raises levels of IGF-1, a related hormone involved in muscle and bone growth. Unlike injectable growth hormone, MK-677 is taken orally, which is a big part of why it’s attracted so much attention online.
MK-677 is not approved for medical use by any government health authority. It remains an investigational compound, meaning it has been studied in clinical trials but never cleared the bar for prescription use. Despite this, it circulates widely in the bodybuilding and anti-aging supplement market.
How MK-677 Works in the Body
Your brain has receptors designed to respond to ghrelin, a hormone your stomach releases when you’re hungry. MK-677 slots into those same receptors and activates them, telling the pituitary gland to pump out growth hormone. In a year-long trial of healthy older adults, MK-677 restored growth hormone and IGF-1 to levels typically seen in younger people. IGF-1 levels rose roughly 39 to 45 percent above baseline in studies lasting 12 to 18 months.
Growth hormone peaks quickly after a dose. In clinical measurements, total growth hormone concentration peaked within about one hour of taking MK-677, though this shifted slightly with continued use (closer to 1.5 hours after several weeks). Because the drug stimulates your body’s own hormone production rather than injecting synthetic growth hormone directly, the resulting hormone release follows a more natural pulsatile pattern.
Because MK-677 mimics ghrelin, it also does what ghrelin does beyond growth hormone release: it increases appetite. This is not a mild side note. Many users report noticeably stronger hunger, which can be either useful or problematic depending on your goals.
Effects on Muscle and Body Composition
The promise most people hear about is more muscle. The clinical picture is more nuanced. In a year-long trial of healthy older adults, MK-677 did increase lean body mass. But it also increased fat mass, and the functional payoff (actual strength or physical performance) was harder to pin down. Researchers noted that reliable functional endpoints couldn’t be assessed due to short study durations and small sample sizes.
A case report tracking someone using MK-677 alongside another compound (LGD-4033) showed a 3.1 percent increase in total lean body mass and a 6.6 percent increase in trunk lean mass. However, total fat mass also climbed 15.4 percent. It’s impossible to separate MK-677’s contribution from the other compound in that case, but the pattern of gaining both lean and fat tissue is consistent with what growth hormone does: it changes body composition, but not exclusively in the direction people hope for.
Bone Density and Turnover
MK-677 increases bone turnover, meaning it speeds up both the building and breakdown of bone tissue. In an 18-month study of postmenopausal women with osteoporosis, MK-677 raised a marker of bone formation (osteocalcin) by about 22 percent and a marker of bone breakdown by 41 percent compared to placebo. When combined with alendronate (a standard osteoporosis drug), it improved bone mineral density at the femoral neck by 4.2 percent. On its own, though, the increases in bone density at most skeletal sites were not significant.
The takeaway is that MK-677 makes bone more metabolically active, but that extra activity doesn’t necessarily translate into stronger bones unless paired with a drug that specifically suppresses bone loss.
Effects on Blood Sugar and Insulin
This is the side effect profile that matters most. Growth hormone naturally makes your cells less responsive to insulin, and MK-677 does the same. In a controlled trial of healthy older adults, fasting blood glucose rose an average of 5 mg/dL after 12 months on MK-677, and insulin sensitivity declined significantly. HbA1c, a measure of longer-term blood sugar control, also crept up.
These changes were statistically significant but relatively small in healthy people. In the group that continued MK-677 for two years, the fasting glucose increase lost statistical significance, suggesting the body may partially adapt over time. Still, for anyone with prediabetes or diabetes, or a family history of either, this effect is a genuine concern. A hip fracture recovery trial in elderly patients had to be stopped early because of adverse effects, with blood sugar changes among the issues.
Other Side Effects
Beyond blood sugar, the side effects of MK-677 largely mirror what you’d expect from elevated growth hormone. Water retention and mild swelling (particularly in the hands and feet) are commonly reported. Joint aches and muscle pain can occur. Increased appetite is nearly universal and can be intense, particularly in the first few weeks.
Because growth hormone influences so many systems, the list of potential effects is long. Some users report improved sleep quality, which aligns with the known relationship between growth hormone and deep sleep. Growth hormone secretion naturally drops with age alongside declines in slow-wave sleep, so restoring growth hormone levels could plausibly improve sleep architecture, though direct MK-677 sleep data from rigorous trials is limited.
Legal and Regulatory Status
MK-677 is not approved for human use in any country. It falls under the World Anti-Doping Agency’s 2025 Prohibited List as a growth hormone secretagogue, classified under “S2: Peptide Hormones, Growth Factors, Related Substances, and Mimetics.” It is banned at all times, both in and out of competition, and categorized as a non-specified substance, which carries stricter penalties for athletes who test positive.
Outside of sports, MK-677 exists in a legal gray zone in many countries. It’s often sold as a “research chemical” rather than a supplement or medication, which allows vendors to sidestep regulations that would apply to drugs or dietary supplements. This means the products available online have no quality control guarantees. Independent lab testing of these products has repeatedly found inaccurate dosing, contamination, or mislabeled ingredients.
What the Research Actually Shows
MK-677 reliably raises growth hormone and IGF-1 levels. That part is well established across multiple trials. What’s far less clear is whether those hormonal changes produce meaningful, lasting benefits for the people taking it. The muscle gains in clinical studies have been modest and accompanied by fat gain. The bone effects are mixed. The metabolic downsides, particularly reduced insulin sensitivity, are consistent and concerning.
Most clinical trials have been small, short, and conducted in elderly populations recovering from specific conditions. Almost no rigorous data exists for the young, healthy adults who make up the majority of people actually using MK-677. Extrapolating results from frail 70-year-olds to a 25-year-old looking to build muscle requires a leap the science doesn’t support. The risk-benefit calculation looks very different when your growth hormone levels are already normal.